Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Completed Initiated May 9, 2022 (4 years ago)

NAD+ Nicotinamide Adenine Dinucleotide

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of assurance of sterility.

Cause type: Sterility / contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections. All sterility / contamination recalls.

What was recalled

NAD+ Nicotinamide Adenine Dinucleotide, Lyophilized powder for reconstitution, Multi-Dose 500 mg per vial, Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155 Orlando, FL 32835. NDC 73198-0083-00.

Affected NDC 73198-0083-00

Compare with the code on your package — it is the most precise check available.

Drug: Adenine

Recalling firm
Olympia Compounding Pharmacy dba Olympia Pharmacy
NDC code
73198-0083-00
Origin
FL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0939-2022 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now completed, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Adenine recalls

See all

Other recalls by Olympia Compounding Pharmacy dba Olympia Pharmacy

All 2022 recalls